FDA Approves New Use of Avastin Plus Chemotherapy for People with Metastatic Colorectal Cancer

“The majority of people diagnosed with metastatic colorectal cancer receive Avastin plus chemotherapy as their initial treatment,” said Hal Barron, M.D., chief medical officer and head of Global Product Development. “These people now have the option to continue with Avastin plus a new chemotherapy after their cancer worsens, which may help them live longer than changing to the new chemotherapy alone.”

More…

Leave a Reply

Your email address will not be published. Required fields are marked *